Back to search
FDAFDA · Food and drugs·Recall number D-1060-2013

Hydroxocobalamin MDV 5 mg/mL (5,000 mcg/mL) Inj., 10 mL vial X 3, Eastern States Compounding Pharmacy, Littleton, NH 03561

Published September 25, 2013 · Recall initiated: September 5, 2013

Summary

FDA records drug Class II recall D-1060-2013, published September 25, 2013 and initiated September 5, 2013. Recalling firm: Northern New England Compounding Pharmacy LLC; Status: Terminated; Reported quantity: 1 Vial; Lot: Lot #: 08022013@34, Exp11/3/2013. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.

Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

Lack of Assurance of Sterility: The pharmacy is recalling one lot of Hydroxocobalamin MDV 5mg/mL due to failed sterility results by a third party contract testing lab. Hence the sterility of the product cannot be assured.

What to do

Voluntary: Firm initiated · Telephone

Get an email when a new FDA recall like this is published

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Manufacturer
Northern New England Compounding Pharmacy LLC
Distributor
CT
Lot
Lot #: 08022013@34, Exp11/3/2013
Risk classification
Class II
Area (FDA)
drug
Country
United States

Related recalls

Questions about this recall

Was Hydroxocobalamin MDV 5 mg/mL (5,000 mcg/mL) Inj., 10 mL vial X 3, Eastern States Compounding Pharmacy, Littleton, NH 03561 recalled?

Yes. FDA published recall D-1060-2013 on September 25, 2013. Reported hazard: Lack of Assurance of Sterility: The pharmacy is recalling one lot of Hydroxocobalamin MDV 5mg/mL due to failed sterility results by a third party contract testing lab. Hence the sterility of the product cannot be assured.

What should I do if I have this product?

Voluntary: Firm initiated · Telephone